cryj2-dna-lamp plasmid vaccine

Allergenexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2012 (NCT01707069)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Tree pollenImmunity, desensitized

    Tree pollen immunity, desensitized

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • cryj2-dna-lamp plasmid vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02146781Phase 1Jun 1, 2014East West Medical Research Institute, Immunomic Therapeutics, Inc.
NCT01966224Phase 1Sep 1, 2013East West Medical Research Institute, Immunomic Therapeutics, Inc.
NCT01707069Phase 1Oct 1, 2012Immunomic Therapeutics, Inc.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Immunomic Therapeutics, Inc.For profit3312012
East West Medical Research InstituteAcademic/Hospital2012013
2 organizations
Page 1 / 1